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ABSTRACT To determine how the hydrophobic surfactant proteins promote insertion of the surfactant lipids into an air/water
interface, we measured the effect of lysophosphatidylcholine (LPC) on adsorption. Existing models contend that the proteins
function either by disordering the lipids or by stabilizing a negatively curved structure located between the adsorbing vesicle and
the interface. Because LPC produces greater disorder but positive curvature, the models predict opposite effects. With vesicles
containing either dioleoyl phosphatidylcholine (DOPC) or the neutral and phospholipids isolated from calf surfactant, LPC
increased the initial rate at which surface tension fell. The ﬁnal surface tension, however, remained well above the value of ;25
mN/m expected for a saturated surface. With two preparations, dioleoyl phosphatidylethanolamine and gramicidin A-DOPC,
which form the negatively curved hexagonal-II (HII) phase and adsorb rapidly, LPC instead had little effect on initial adsorption
but delayed the fall of surface tension below ;30 mN/m. LPC produced a similar inhibition of the late adsorption for extracted
calf surfactant. Unlike dioleoyl phosphatidylethanolamine and gramicidin A-DOPC, small-angle x-ray scattering and 31P-nuclear
magnetic resonance for extracted calf surfactant detected no evidence for the HII phase. Our results indicate that although LPC
can promote the initial adsorption of vesicles containing only lamellar lipids, it inhibits the facilitation by the hydrophobic proteins
of late adsorption. Our ﬁndings support a model in which the surfactant proteins accelerate adsorption by producing a focal
tendency to stabilize a negatively curved kinetic intermediate without a general shift to the HII phase.
INTRODUCTION
In the lungs, pulmonary surfactant adsorbs quickly to the air/
water interface. When a baby ﬁrst creates the interface during
its initial breath, pulmonary mechanics are normal within the
ﬁrst few respiratory cycles (1,2). For lungs in which
prolonged ventilation at constant tidal volume has reduced
surfactant function, a single deep inspiration, which expands
the air/water interface and allows adsorption of fresh
surfactant vesicles, restores normal pulmonary mechanics
during the ﬁrst exhalation (3). Adsorption therefore can form
a ﬁlm in situ at least within seconds.
Classical single-molecule surfactants and vesicles of
pulmonary surfactant adsorb by processes that are funda-
mentally distinct. Classical surfactants adsorb as monomers,
and increases in concentration above the critical micelle
concentration (cmc) have little effect on adsorption. The low
solubility of biological phospholipids makes determination
of their cmc difﬁcult, but the best estimates suggest that
values are no higher than nanomolar (4) and probably lower.
The dependence of adsorption on concentrations well above
those levels suggests that pulmonary surfactant must insert
into the interface as intact vesicles. Direct observation of
adsorption conﬁrms that conclusion (5,6).
Studies in vitro at concentrations below the levels in the
lungs show that adsorption of vesicles containing the
surfactant lipids, without the proteins, is limited by an
energy barrier to interfacial insertion. The process is con-
siderably slower than if diffusion alone determined the rate
(7). The dependence of kinetics on temperature indicates that
an energy of activation is required to achieve adsorption
(7,8). Several components of pulmonary surfactant increase
the rate of adsorption, presumably by lowering that energy of
activation. The hydrophobic surfactant proteins, and specif-
ically SP-B, have the greatest effect (9). Other functions have
been proposed for SP-B, including the ability to minimize
collapse of compressed monolayers and to promote respread-
ing of collapsed material into an expanding interface. SP-B’s
effect on adsorption, however, represents its best docu-
mented and most impressive function.
The consequences of ventilating lungs in the absence of
SP-B suggest that the same energy barrier that limits ad-
sorption in vitro is also present in vivo. Although patients
(10) and mice (11) that congenitally lack functional SP-B
have normal levels of surfactant lipids at the end of full-term
pregnancies, they nonetheless develop the respiratory dis-
tress syndrome, in which the process of ventilation injures
the thin epithelial barrier between capillary blood and al-
veolar air. In genetically modiﬁed adult animals, when pro-
duction of SP-B stops, the lungs develop a similar injury
(12). Dipalmitoyl phosphatidylcholine (DPPC), which forms
metastable ﬁlms that resist collapse during compression,
functions poorly in premature infants (13) as a single-com-
ponent therapeutic surfactant, presumably because of its
slow rate of adsorption. These observations suggest that
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rapid adsorption is not only characteristic of pulmonary
surfactant but also physiologically essential.
Two mechanisms have been proposed to explain how dif-
ferent constituents promote adsorption. The original model
suggests that factors such as the unsaturated phospholipids
and the hydrophobic surfactant proteins disrupt ordered
structures (14–16). Relative to other phospholipids, pulmo-
nary surfactant contains an unusually high content of DPPC
(17), which in single-component vesicles remains in the
highly ordered gel (Lb9) phase at physiological temperatures.
By disrupting the gel phase, different constituents would
produce more ﬂuid structures that might transform more
rapidly from bilayer to interfacial ﬁlm. More recent studies
have shown that factors that can or should induce formation
of the negatively curved hexagonal-II (HII) phase also pro-
mote adsorption (18–20). These results support a second
model in which constituents such as the surfactant proteins
stabilize negatively curved structures, with a concave hy-
drophilic face, that bridge the gap between the vesicles and
the interface, analogous to the stalk intermediate proposed as
a crucial step in the fusion of two bilayers (21–23). Negative
curvature and disordered lipids could of course both con-
tribute to faster adsorption. The relative importance of the
two characteristics, however, is uncertain and is signiﬁcant
both for the design of therapeutic surfactants and for
understanding how pulmonary surfactant functions in the
lungs.
Lysophosphatidylcholine (LPC) should have opposite
effects on the two proposed mechanisms. LPC should
produce more disorder (24–26), but it also forms structures
with positive curvature, aggregating into micelles at lower
concentrations and the hexagonal-I phase at higher levels
(27). LPC should therefore promote adsorption if lipid
disorder determines the kinetics but act as an inhibitor if
negative curvature is more important. In the studies reported
here, we ﬁrst characterized the adsorption of vesicles con-
taining only lipids and how LPC affected that process. We
then conﬁrmed that LPC inhibits adsorption of two prepa-
rations that form the negatively-curved hexagonal-II (HII)
phase and determined if LPC produces a similar inhibition of
adsorption promoted by the hydrophobic surfactant proteins.
MATERIALS AND METHODS
Materials
Calf lung surfactant extract (CLSE), prepared as described previously (28),
was provided by Dr. Edmund Egan (ONY, Amherst, NY). The complete set
of neutral and phospholipids (N&PL) in CLSE were obtained by using gel
permeation chromatography to remove the hydrophobic proteins (29).
Previous studies have conﬁrmed that the relative proportions of the different
head groups, the fatty acid constituents, and cholesterol are the same in
N&PL and CLSE (29,30).
Gramicidin A (GrA) from Bacillus brevis of$90% purity was purchased
commercially and used as received (Product 50845, Sigma-Aldrich, St.
Louis, MO). Dioleoyl phosphatidylethanolamine (DOPE, Product 850725),
dioleoyl phosphatidylcholine (DOPC, Product 850375), and egg LPC
(Product 830071), which contains predominantly saturated acyl chains, were
obtained from Avanti Polar Lipids (Alabaster, AL), found to form a single
spot on thin layer chromatography (31) and used without further puriﬁca-
tion. Dialysis used tubing (S41300-4, Fisher Scientiﬁc, Pittsburgh, PA) with
a 4.8-nm-diameter pore and a cutoff of 12 kDa. Highly puriﬁed water
obtained with a multicartridge system (Barnstead International, Dubuque,
IA) was used throughout the experimental work. All other chemicals and
solvents were analytical grade.
Methods
Preparation of lipid vesicles
Measurements of adsorption used samples prepared by two procedures
designed to incorporate LPC either into both leaﬂets of the bilayer or
preferentially into the outer leaﬂet. For incorporation into both leaﬂets, LPC
was mixed in appropriate amounts with the other components in chloroform
solutions. After complete mixing, the solvent was evaporated in round-
bottomed test tubes under a stream of nitrogen. The resulting ﬁlm was placed
in a vacuum desiccator overnight to remove the last traces of solvent and
then hydrated overnight with 10 mM HEPES, pH 7.0, 150 mM NaCl (HS),
or in the case of N&PL and CLSE, with HS containing 1.5 mM CaCl2
(HSC). The ﬁnal concentration of phospholipid other than LPC, determined
by assay of total phosphate (32), was 30 mM. The samples were then
resuspended by several cycles of sequential heating to 50C with vortexing
for 3 min followed by cooling in an ice bath. The crude vesicles were
dispersed further in a water-bath sonicator (model 3510, Branson, Danbury,
CT) for 30 min. For incorporation of LPC into the outer leaﬂet, LPC was
omitted from the original mixtures and then added as a micellar dispersion to
the lipid vesicles. With both procedures, the vesicles with LPC were
incubated overnight at 37C before the kinetics of adsorption were
measured.
Experiments to determine the effects of dialysis used 2-ml samples at 5
mM phospholipid dialyzed for at least 6 h against each of ﬁve successive
changes of 1 liter of buffer. The diameter of the pores in the dialysis tubing
was well below the hydrodynamic radius, determined by dynamic light
scattering (DynaPro Light-Scattering Instrument, Proteins Solutions,
Charlottesville, VA), of the dispersed aggregates with and without the
highest dose of LPC (Table 1). Measurements of adsorption were conducted
after dilution of the dialyzed sample to the appropriate concentration.
Measurements of surface tension
Surface tension was measured using a force transducer (KSV Instruments,
Helsinki, Finland) attached to a 0.3-cm-wide Wilhelmy paper plate. Surface
tension was recorded directly to a desktop computer using programs
constructed with the graphical user interface LabVIEW (National Instru-
ments, Austin, TX). The measurements used a Teﬂon beaker with a 4.0 cm2
cross section in a fully humidiﬁed chamber maintained at 37.06 0.5C with
a circulating water bath. A ﬁxed volume of 20 ml buffer, using HSC for
CLSE and N&PL and HS for the other preparations, was added to the Teﬂon
beaker, and after a stable temperature had been reached, 100 ml of the
dispersed vesicles at 30 mM non-LPC phospholipid was injected into the
TABLE 1 Hydrodynamic radii (nm) of particles in
dispersed samples
LPC/PC (mol/mol) 0 0.25 0.30
DOPC 50.7 6 5.3 62.0 6 2.8 –
GrA-DOPC 138 6 3 76.5 6 5.2 –
N&PL 86.3 6 0.8 – 69.3 6 0.9
CLSE 144 6 12 – 114 6 3
The intensity of scattering prevented accurate measurements of hydrody-
namic radii for samples with DOPE.
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subphase to a ﬁnal concentration of 150 mM. After gentle stirring for 15 min
to provide complete mixing, experiments were begun by suctioning the ﬁlm
from the interface (7,8). Measurements of surface tension as a function of
time are shown as representative curves to illustrate features that can be lost
in averaged traces, with mean 6 SD for at least three experiments shown at
selected points to indicate the variance of the data.
Small-angle x-ray scattering
Measurements of small-angle x-ray scattering (SAXS) from dispersions of
CLSE used a home-built x-ray diffractometer. The x-ray generator (XRD-
3000, Phillips, Almelo, The Netherlands) operates at 45 kV and 20 mA with
a sealed ﬁne-focus copper tube. The collimated monochromatic x-ray beam
(l ¼ 1.54 A˚) was produced using a b-nickel ﬁlter and a pinhole collimator.
Lead stearate (d ¼ 49.8 A˚) was used as the calibrating standard. Mea-
surements were performed on CLSE dispersions at 30 mM phospholipid
sealed in glass capillaries (1 mm diameter) maintained at 37.06 0.2C. The
diffraction patterns were collected using a linear position-sensitive detector
(spatial resolution of 92 mm/channel) interfaced to a personal computer
through a multichannel analyzer (ND-53, Nuclear Data, Canberra Industries,
Meriden, CT). Data were collected for each sample until the integrated
intensity reached a common ﬁxed value of 500,000 counts. The original data
obtained as intensity versus channel number were converted to intensity
versus q-spacing using the distances from sample to detector and from
channel to the beam-stop, along with the wavelength of the x-rays. To
correct for small differences in intensity caused by the different capillary
tubes, each set of data was normalized with respect to the peak immediately
adjacent to the beam-block that results from scattering in air.
Nuclear magnetic resonance
Proton-decoupled 31P- NMR spectra from nonspinning dispersed samples of
CLSE at 30 mM phospholipid were collected on a spectrometer (AMX-400,
Bruker, Billerica, MA) using 2H-NMR as an internal lock. Each spectrum
was collected at a probe temperature of 37C with 2000 scans at a 2-s
repetition interval using a 15 pulse width and 100 kHz sweep width. A
linewidth-broadening factor of 100 Hz was applied before Fourier trans-
formation. Zero in the frequency domain corresponded to the chemical shift
of phosphoric acid in D2O.
RESULTS
Model lamellar lipids
Because of a prediction by one of the models, we used two
methods to combine LPC with the other lipids. The hypo-
thetical negatively curved structure between the vesicle and
the interface would form from the outer leaﬂet of the bilayer.
LPC conﬁned to that outer leaﬂet should still inhibit ad-
sorption. In one set of experiments, LPC was added to
existing vesicles so that it would have access only to the
external monolayer. LPC itself, however, is surface active
and capable of lowering surface tension (Fig. 1). To ensure
that changes in surface tension reﬂected adsorption of ves-
icles rather than free LPC, separate experiments used LPC
dispersed together with the other lipids. Although this
method of incorporating the compound allowed access to
both sides of the bilayer, prior studies have shown that LPC
distributes predominantly to the outer leaﬂet (33–42). The
two protocols were therefore likely to produce similar
vesicles.
For all experiments, we also tested whether dialysis
affected the kinetics of adsorption. The protocol for dialysis
eliminated the ability to lower surface tension of samples
containing only LPC. The concentration of samples contain-
ing only the other phospholipids, however, was unaffected.
Dialysis therefore should have removed any free LPC but not
LPC incorporated into vesicles.
LPC enhanced the initial reduction in surface tension of
samples containing only lamellar phospholipids (Fig. 2).
Vesicles of DOPC alone, without LPC, lowered surface
tension slowly and to a limited extent, reaching only 63.1 6
0.5 mN/m after 300 min (Fig. 2). LPC produced a dose-
dependent increase in the rate at which surface tension fell
and also lowered the ﬁnal surface tension (Fig. 2). This faster
reduction in surface tension occurred both when LPC was
dispersed together with DOPC and when it was added
subsequently to preformed vesicles. Dialysis had no effect.
The ﬁnal surface tension, however, remained well above the
expected equilibrium spreading tension of ;24 mN/m, at
which ﬁlms of phospholipids would saturate the interface
(43). At the highest LPC/DOPC ratio of 0.25, surface tension
reached only 46.6 6 0.3 mN/m at 300 min. In the presence
of LPC, adsorption of DOPC vesicles, although faster, re-
mained incomplete.
LPC produced a similar effect with the N&PL obtained
from extracted calf surfactant, CLSE, by using gel perme-
ation chromatography to remove the hydrophobic surfactant
proteins (29,30). LPC, whether dispersed together with the
FIGURE 1 Adsorption of LPC. Curves show the variation of surface
tension for individual experiments following removal of the interfacial ﬁlm
from above dispersions of LPC in HSC buffer at 37C. Curves are
representative of at least three experiments, with symbols at selected times to
distinguish among different concentrations.
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N&PL or added to preexisting vesicles, produced a dose-
dependent increase in the rate at which surface tension fell
(Fig. 3). Dialysis had no effect. Like the samples of LPC-
DOPC, adsorption was incomplete, and the ﬁnal surface
tension after 300 min remained $39 mN/m. LPC therefore
produced similar effects on DOPC and N&PL, with faster
initial adsorption that stagnated well before complete ﬁlling
of the interface.
Lipids that form HII structures
One premise of our studies was that LPC, which forms
structures with positive curvature, would inhibit adsorption
of preparations that proceed via intermediates with nega-
tive curvature. Prior studies with two systems have shown
that negatively curved structures produce faster adsorption.
Both GrA-DOPC (20) and mixtures of lipids that contain
phosphatidylethanolamine (PE), either as DPPC-PE or as
DPPC-PE-phosphatidylglycerol (18,19), adsorb rapidly un-
der conditions at which the negatively curved HII phase is or
should be present. In the current studies, before testing the
effects of LPC on pulmonary surfactant, we ﬁrst determined
whether LPC would in fact inhibit adsorption by GrA-DOPC
(0.07 mol/mol) and by DOPE.
DOPE without LPC adsorbed to the expected ﬁnal surface
tension of;24 mN/m at rates too fast to distinguish features
FIGURE 2 Effect of LPC on the adsorption of DOPC. Samples contained
150 mM DOPC in HS buffer at 37C. Curves give the complete set of data
for an individual experiment. Symbols give mean 6 SD for at least three
experiments at selected times to indicate the variance of the data. (A) LPC
and DOPC combined in organic solvent and dispersed together. (B) Dis-
persed LPC added to vesicles of DOPC. (C) Effect of dialysis on adsorption
at the highest LPC/DOPC ratio.
FIGURE 3 Effect of LPC on the adsorption of N&PL. Samples contained
100 mM phospholipid in HSC buffer at 37C. Curves give the complete set
of data for an individual experiment. Symbols give mean 6 SD for at least
three experiments at selected times to indicate the variance of the data. (A)
LPC and N&PL combined in organic solvent and dispersed together. (B)
Dispersed LPC added to vesicles of N&PL. (C) Effect of dialysis on
adsorption at the highest LPC/N&PL ratio.
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of the adsorption isotherm (Fig. 4). LPC, whether added
separately to the dispersed DOPE or mixed and then dis-
persed together, slightly delayed the initial decrease in sur-
face tension. For both methods of combination, the LPC also
introduced a plateau at an intermediate surface tension of
;44–55 mN/m (Fig. 4, A and B). The duration of the plateau
depended on the amount of added LPC, extending beyond
the 3-h length of the experiment for the highest LPC/DOPE
ratio of 0.25 but terminating for lower amounts with a
steepened slope until surface tension approached the ex-
pected ﬁnal value of ;24 mN/m. With samples prepared by
both methods for combining the lipids, the plateau persisted
after dialysis (Fig. 4 C). Incorporation of LPC into the DOPE
structures therefore produced a minor effect on the initial fall
in surface tension but inhibited adsorption below an inter-
mediate surface tension.
LPC produced similar effects on adsorption of GrA-
DOPC, which also adsorbs rapidly under conditions at which
it forms HII structures (20). Samples of GrA-DOPC, without
LPC, adsorbed along isotherms that included a previously
observed (20) distinct inﬂection point (Fig. 5). Surface
tension fell at slowing rates to ;50 mN/m, but the slope
then steepened. Added LPC had relatively little effect on
the initial fall in surface tension or the late acceleration of
FIGURE 4 Effect of LPC on adsorption of DOPE. Curves show the varia-
tion of surface tension after removal of the surface ﬁlm from a dispersion of
150 mM DOPE in HS buffer at 37C. Curves are representative of at least
three different experiments, with mean 6 SD shown at selected times. (A)
LPC and DOPE dispersed together. Legend applies to panels A and B. (B)
LPC added to DOPE after separate dispersion. (C) Effect of dialysis on
adsorption of LPC-DOPE prepared by both methods of combination.
FIGURE 5 Effect of LPC on adsorption of GrA-DOPC (0.07 mol:mol).
Curves show the variation of surface tension after removal of the surface ﬁlm
from a dispersion of 150 mMDOPC with GrA in HS buffer at 37C. Curves
are representative of at least three experiments, with mean 6 SD shown at
selected times to indicate the variance of the data. Split time scale illustrates
early as well as late events. (A) LPC dispersed along with GrA/DOPC. (B)
LPC added to GrA/DOPC after separate dispersion. (C) Effect of dialysis on
adsorption of LPC-GrA/DOPC dispersions prepared by both methods of
combination.
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adsorption, but it delayed the inﬂection point (Fig. 5). Con-
sequently, LPC produced a dose-dependent prolongation
of a plateau at intermediate surface tensions. Results were
similar for the two methods of combination, and dialysis
produced little change (Fig. 5 C). Like its effect on DOPE,
LPC had little effect on the initial adsorption of GrA-DOPC
but a major inhibition of the late acceleration.
Effect of surfactant proteins
Experiments with CLSE used the same two methods to
incorporate LPC into bilayer vesicles. Samples containing
only CLSE, without LPC, produced results similar to
previously published studies (7,20,44). Surface tension fell
at slowing rates to an inﬂection point at ;35 mN/m, after
which the slope became steeper until surface tension reached
a ﬁnal value of ;24 mN/m (Fig. 6). LPC added by both
methods had minimal effect on the initial fall in surface
tension to ;40–45 mN/m, but it produced a dose-dependent
delay in the inﬂection point and, therefore, a plateau at ;40
mN/m. Greater amounts of LPC produced little change in the
surface tension of the plateau or in the slope of the ﬁnal drop
in surface tension. For the three doses of LPC, the isotherms
after the plateau during the drop to their ﬁnal surface tension
were roughly parallel. Dialysis produced no signiﬁcant
changes (Fig. 6 C). LPC therefore produced alterations in the
adsorption of CLSE that were similar to its effects on DOPE
and particularly on GrA-DOPC, delaying the fall in surface
tension below an intermediate surface tension of;40 mN/m.
These results raised the possibility that, like DOPE and
GrA-DOPC, the surfactant lipids with the hydrophobic
proteins might form the HII phase. Both SAXS (Fig. 7) and
31P-NMR (Fig. 8) from CLSE detected only lamellar
structures. Under the same conditions at which the samples
adsorbed rapidly, the d-spacing of the two peaks in SAXS
had the relative values of 1:2 expected for multilamellar
vesicles (Fig. 7), and no intensity above baseline at the d1/d2
of 1.73 expected for the second-order diffraction peak from a
hexagonal phase (45). 31P-NMR did show the appearance of
an isotropic peak, but the signal otherwise ﬁt well to the
shape expected for vesicles, without a component contrib-
uted by tubular structures (Fig. 8). In contrast to the
preparations with PE and GrA, the hydrophobic proteins
achieved their effect on adsorption without inducing a
general shift to the HII phase.
DISCUSSION
LPC inhibits the effects of surfactant proteins
The principal result of these studies is that LPC inhibits the
ability of the surfactant proteins to promote adsorption of
the surfactant lipids to equilibrium surface tensions. In the
absence of the proteins, the surfactant lipids of N&PL adsorb
only to intermediate surface tensions of ;45 mN/m, well
above the equilibrium level. The additional presence of the
hydrophobic proteins in CLSE accelerates the initial fall in
surface tension to ;45 mN/m, but they also produce an
inﬂection point in the isotherm and a late acceleration (7).
Despite a more crowded interface at lower surface tensions,
adsorption occurs more rapidly below ;40 mN/m. LPC
produces no discernible effects on the initial drop in surface
tension, but it causes a dose-dependent delay in the inﬂection
point. The slope of the ﬁnal drop in surface tension remains
approximately unchanged, and consequently, LPC produces
a plateau at a roughly constant surface tension of ;35–40
mN/m. Despite the absence of any major effect on early
FIGURE 6 Adsorption of CLSE in the absence and presence of LPC.
Curves show the variation of surface tension after removal of the surface ﬁlm
from a dispersion of 100 mM surfactant phospholipid at 37C in HSC buffer.
Curves are representative of three experiments under the same conditions.
Symbols give mean 6 SD at speciﬁc times to indicate the variation among
different experiments. (A) LPC and CLSE dispersed separately and then
combined. (B) LPC and CLSE mixed and then dispersed together. (C)
Samples prepared by both methods of combination and then dialyzed.
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adsorption, LPC inhibits the ability of the proteins to pro-
mote interfacial insertion of the vesicles to achieve a sat-
urated ﬁlm.
LPC similarly inhibits systems in which factors that
induce negative curvature also promote adsorption. Both PE
(18,19) and GrA (20) induce phosphatidylcholines to form
the negatively curved HII phase and to adsorb more rapidly.
GrA, like the surfactant proteins, produces both a faster
initial fall in surface tension and a late acceleration, so that
DOPC, which alone stalls well short of the equilibrium
spreading tension, will reach 24 mN/m. For both DOPE and
GrA-DOPC, LPC inhibits the ﬁnal fall in surface tension,
and generates a plateau of dose-dependent duration at an
intermediate surface tension. The inhibitory effects by the
positively curved LPC are similar for adsorption promoted
by the hydrophobic proteins and by the two factors known to
produce negative curvature.
This observation adds to the chain of evidence concerning
how the proteins facilitate adsorption. Although the role of
the proteins during the subsequent unraveling of the sur-
factant aggregates is uncertain, their ability to promote ad-
sorption when conﬁned to the interface suggests that they
facilitate at least the initial interaction of the vesicles with the
surface. The similar (46) or equivalent (47) effects of factors
in the vesicles and at the interface argue for a rate-limiting
kinetic intermediate that is equally accessible from both
locations. The ability of PE and GrA, which induce negative
spontaneous curvature, to promote adsorption suggests that
the kinetic intermediate might also be negatively curved. The
similar effects of PE, GrA, and the hydrophobic surfactant
proteins would then reﬂect a common stabilization of that
rate-limiting structure. The similar kinetics, however, could
nonetheless occur for processes that proceed along different
pathways. The inhibition by LPC of adsorption promoted by
factors with negative curvature and by the hydrophobic
proteins provides additional support for the model in which
the proteins stabilize a negatively curved structure interme-
diate between the interface and the vesicle.
In contrast to PE and GrA, the surfactant proteins promote
adsorption without inducing formation of the HII phase.
Although with 17% (w/w) SP-B, 2H-NMR does show
changes in the structure of DPPC bilayers consistent with
permanent curvature (48), for CLSE, with ;1.5% (w/w)
hydrophobic protein, SAXS and 31P-NMR detect only
lamellar structures (Figs. 7 and 8). The absence of the HII
phase suggests that the effects of the proteins may be
particularly focal, consistent with the ability of an individual
SP-B to produce the full enhancement of adsorption (44).
The proposed rate-limiting intermediate would require only
a local effect where the vesicle contacts the interface. At
the surface, the reduction in interfacial energy achieved by
forming a ﬁlm could permit structures that would be dis-
allowed in the bulk subphase. The small amount of protein
present in the surfactant mixture would then produce sig-
niﬁcant effects on their local environment and on rates of
adsorption without causing a generalized phase transition.
A focal effect could be crucial in resolving the functional
dichotomy faced by pulmonary surfactant. In the lungs, the
surfactant lipids must adsorb rapidly to form the functional
ﬁlm but then avoid the reverse process of desorption when
the decreasing alveolar surface area compresses the ﬁlm
during exhalation (49). The same global curvature that pro-
motes rapid adsorption by preparations that form the HII
phase should destabilize the compressed ﬁlm, limiting access
to surface tensions below the equilibrium spreading values of
;24 mN/m. The PEs, for instance, which adsorb rapidly,
FIGURE 7 Small-angle x-ray scattering (SAXS) from dispersions of
CLSE. Samples contained 30 mM phospholipid in HSC buffer at 37C.
Labels indicate peaks adjacent to the beam-stop (BS), and for ﬁrst- (d1) and
second-order (d2) diffraction.
FIGURE 8 31P-NMR for dispersions of CLSE. Samples contained 30 mM
phospholipid in HSC at 37C.
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failed during compression to reach surface tensions much
below equilibrium values (19). A more focal effect produced
by the proteins could be more easily eliminated. The sur-
factant proteins and lipids, which are secreted together by
the type II pneumocytes, separate at some point in the al-
veolus (50). If the separation occurs during compression of
the adsorbed ﬁlm, exclusion of the protein would eliminate
the source of localized curvature, resulting in a more stable
ﬁlm.
Our studies used concentrations substantially lower than
the levels present in the alveolus. This difference seems
unlikely to alter the relevance of our ﬁndings to effects of
the proteins in situ. The dependence of chemical kinetics on
concentration is well known, and the adsorption of pul-
monary surfactant in that respect is well behaved (7). In-
creased concentration could conceivably also change the
nature of the lipid-protein aggregates by shifting the system
to a different region of the phase diagram. Electron micro-
graphs, however, of thin sections from the lungs indicate that
water remains in excess (51,52). Free water should therefore
coexist with the same hydrated phospholipid structures in
vitro and in situ, with differences in concentration shifting
the system along the tieline between those two phases.
Although the higher concentrations in the lungs should pro-
duce quantitatively faster adsorption, the qualitative effects
demonstrated here of the proteins and of LPC should remain
valid in situ.
LPC promotes initial adsorption of the lipids
A second major ﬁnding is that LPC promotes the initial fall
in surface tension for vesicles containing only lipids. For
both DOPC and N&PL, LPC has minimal effect on the ﬁnal
surface tension, which remains .40 mN/m, well above the
expected equilibrium levels. In both cases, however, LPC
greatly increases the rate at which surface tension falls to that
ﬁnal value. LPC therefore produces opposite effects on early
and late adsorption of the surfactant lipids, promoting the
initial drop in surface tension but inhibiting the ﬁnal ap-
proach to equilibrium, which requires the surfactant proteins.
We speculate that the different effects of LPC on early and
late adsorption distinguish either two different pathways or
two processes that affect progress along the same pathway.
In either case, the importance of LPC’s known effects on
disorder and curvature would vary with surface tension. This
variation would presumably reﬂect the different interfacial
energies that provide the driving force for adsorption. The
higher initial surface tension might then be adequate to drive
adsorption that requires only disorder but insufﬁcient for
insertion into a denser ﬁlm. Adsorption via a negatively
curved structure would occur at all stages, and at lower sur-
face tensions, with a reduced driving force, interfacial inser-
tion could occur only by that mechanism. The two principal
original models, which contend that factors promote adsorp-
tion by increasing disorder or by inducing negative curva-
ture, would then both be correct, although the effects of
disorder would be evident only at higher surface tensions.
SUMMARY
In summary, LPC promotes the adsorption of vesicles that
can reduce surface tension only to an intermediate value but
inhibits adsorption to lower surface tensions by preparations
that can form saturating ﬁlms. These results, along with
previous reports, suggest that adsorption involves initial in-
sertion of vesicles into the interface by a process that requires
only disordered lipids, and a later insertion into a denser ﬁlm
that must proceed via a structure with signiﬁcant negative
curvature, which is stabilized by the hydrophobic surfactant
proteins and in particular by SP-B.
CLSE was provided by Dr. Edmund Egan (ONY, Amherst, NY).
These studies were funded by the National Institutes of Health (HL 54209).
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